Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,830 | 415 | 97.7% |
| Education | $139.93 | 9 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $554.38 | 48 | $0 (2022) |
| Amgen Inc. | $476.74 | 34 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $451.93 | 32 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $420.79 | 43 | $0 (2022) |
| PFIZER INC. | $368.75 | 29 | $0 (2024) |
| ABBVIE INC. | $357.67 | 31 | $0 (2024) |
| Amarin Pharma Inc. | $310.19 | 8 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $299.63 | 23 | $0 (2018) |
| Astellas Pharma US Inc | $225.89 | 14 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $223.95 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.52 | 4 | ABBVIE INC. ($46.01) |
| 2023 | $306.74 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($85.75) |
| 2022 | $258.24 | 14 | Amgen Inc. ($66.35) |
| 2021 | $740.99 | 43 | AbbVie Inc. ($130.13) |
| 2020 | $329.30 | 21 | Janssen Pharmaceuticals, Inc ($74.50) |
| 2019 | $622.20 | 37 | Amarin Pharma Inc. ($150.30) |
| 2018 | $1,536 | 106 | Novo Nordisk Inc ($229.46) |
| 2017 | $2,097 | 184 | Novo Nordisk Inc ($296.11) |
All Payment Transactions
424 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: UROLOGY | ||||||
| 05/09/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: WOMENS HEALTH | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $85.75 | General |
| Category: Gastroenterology | ||||||
| 09/12/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: WOMENS HEALTH | ||||||
| 07/27/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Bone Health | ||||||
| 07/17/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/30/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Optics | ||||||
| 01/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 12/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Inflammation | ||||||
| 09/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 698 | 1,757 | $150,716 | $78,911 |
| 2022 | 14 | 688 | 1,545 | $152,611 | $82,767 |
| 2021 | 16 | 791 | 1,745 | $168,649 | $89,540 |
| 2020 | 15 | 952 | 2,020 | $184,699 | $85,850 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 597 | $93,132 | $49,428 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 238 | $26,180 | $14,180 | 54.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 81 | $8,100 | $4,776 | 59.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 34 | $6,290 | $3,217 | 51.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 27 | 31 | $3,100 | $1,867 | 60.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $2,200 | $1,568 | 71.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,665 | $1,276 | 47.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 56 | 56 | $1,568 | $1,205 | 76.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 119 | $5,355 | $1,128 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 20 | $1,100 | $157.80 | 14.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 48 | 212 | $424.00 | $82.60 | 19.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 42 | 301 | $602.00 | $26.95 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 565 | $88,140 | $49,042 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 223 | $24,530 | $13,713 | 55.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 123 | $10,890 | $6,631 | 60.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 39 | $6,165 | $4,018 | 65.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 29 | 37 | $3,070 | $1,961 | 63.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 16 | 62 | $3,720 | $1,826 | 49.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 58 | 58 | $3,465 | $1,737 | 50.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $2,870 | $1,587 | 55.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $1,177 | $688.53 | 58.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 16 | $2,400 | $638.08 | 26.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 49 | $2,205 | $480.86 | 21.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 39 | 42 | $2,505 | $394.77 | 15.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 21 | 100 | $808.00 | $36.61 | 4.5% |
About Dr. James Wilhite, M.D
Dr. James Wilhite, M.D is a Internal Medicine healthcare provider based in Tuscaloosa, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043329808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Wilhite, M.D has received a total of $5,970 in payments from pharmaceutical and medical device companies, with $79.52 received in 2024. These payments were reported across 424 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,830).
As a Medicare-enrolled provider, Wilhite has provided services to 3,129 Medicare beneficiaries, totaling 7,067 services with total Medicare billing of $337,068. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Tuscaloosa, AL
- Active Since 08/29/2006
- Last Updated 12/16/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043329808
Products in Payments
- ENTRESTO (Drug) $434.90
- Victoza (Drug) $374.75
- Vascepa (Drug) $310.19
- XARELTO (Drug) $300.77
- Prolia (Biological) $291.97
- Ozempic (Drug) $139.59
- GEMTESA (Drug) $139.43
- Myrbetriq (Drug) $133.11
- TOUJEO (Drug) $130.18
- TRELEGY ELLIPTA (Drug) $128.85
- UBRELVY (Drug) $126.17
- JANUVIA (Drug) $122.94
- INVOKANA (Drug) $120.02
- STIOLTO (Drug) $117.96
- LONHALA MAGNAIR (Drug) $108.95
- XIFAXAN (Drug) $104.94
- Livalo (Drug) $102.85
- AcrySof IQ PanOptix (Device) $102.60
- JARDIANCE (Drug) $92.10
- VIAGRA (Drug) $85.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tuscaloosa
Amit Shah, M.d, M.D
Internal Medicine — Payments: $43,670
Nancy Tactuk Romanenko, Md, MD
Internal Medicine — Payments: $21,072
Dr. Susan Bostick, M.d, M.D
Internal Medicine — Payments: $16,499
Dr. Debra Davis, M.d, M.D
Internal Medicine — Payments: $15,945
Edward Carraway, M.d, M.D
Internal Medicine — Payments: $11,310
Julie Wright, Crnp, CRNP
Internal Medicine — Payments: $5,782